Research ArticleResearch Letter
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable and Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: https://doi.org/10.3122/jabfm.2019.03.180176
Christina Mangurian
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MASAishat Giwa
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MHIErin Brosey
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MSMartha Shumway
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
PhDJames Dilley
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MDElena Fuentes-Afflick
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MPHEliseo J. Pérez-Stable
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MDDean Schillinger
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD
Article Figures & Data
Figures
Tables
- Table 1.
Preferences for Type of Clinician Who Should Be Conducting Metabolic Monitoring of People with Severe Mental Illness
Statement Provider Type* Psychiatrists Primary Care Clinicians Disagree Agree Disagree Agree N % N % N % N % Primary care clinicians should screen not psychiatrists† 30 70 14 30 52 33 102 66 Psychiatrists should screen even if the patient has established primary care‡ 10 20 39 80 63 40 93 60 ↵* Notably, there were minor differences in the number of providers responding to these questions. For example, 47 psychiatrists and 154 primary care clinicians answered the first statement and 49 psychiatrists and 156 primary care clinicians answered the second.
↵† Primary care clinicians were more likely than psychiatrists to agree with this statement (P < .001).
↵‡ Psychiatrists were more likely than primary care clinicians to agree with this statement (P = .011).
In this issue
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176
Jump to section
Related Articles
- No related articles found.